Literature DB >> 29359661

Colchicine Pharmacokinetics and Mechanism of Action.

Christos Angelidis1, Zoi Kotsialou1, Charalampos Kossyvakis2, Agathi-Rosa Vrettou1, Achilleas Zacharoulis1, Fotios Kolokathis1, Vasilios Kekeris2, Georgios Giannopoulos2.   

Abstract

Colchicine is a tricyclic, lipid-soluble alkaloid derived from the plant of the Lily family Colchicum autumnale, sometimes called the "autumn crocus". It is predominantly metabolized in the gastrointestinal tract. Two proteins, P-glycoprotein (P-gp) and CYP3A4 seem to play a pivotal role, governing its pharmacokinetic. The commonest side effects are gastrointestinal (nausea, vomiting and particularly dose-related-diarrhea) occurring in 5-10% of patients. Colchicine exerts its unique action mainly through inhibition of microtubule polymerization. Microtubule polymerization affects a variety of cellular processes including maintenance of shape, signaling, division, migration, and cellular transport. Colchicine interferes with several inflammatory pathways including adhesion and recruitment of neutrophils, superoxide production, inflammasome activation, the RhoA/Rho effector kinase (ROCK) pathway and the tumor necrosis factor alpha (TNF-α) -induced nuclear factor κΒ (NF-κΒ) pathway attenuating the inflammatory response. This concise paper attempts to give a brief review of its pharmacokinetic properties and its main mechanisms of action. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Colchicine; inflammation; mechanism of action; microtubules; pharmacokinetics; toxicity.

Mesh:

Substances:

Year:  2018        PMID: 29359661     DOI: 10.2174/1381612824666180123110042

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  28 in total

1.  Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Authors:  Hakan Emmungil; Ufuk İlgen; Sezin Turan; Samet Yaman; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

2.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

Review 3.  Colchicine for the treatment of COVID-19.

Authors:  Agata Mikolajewska; Anna-Lena Fischer; Vanessa Piechotta; Anika Mueller; Maria-Inti Metzendorf; Marie Becker; Elena Dorando; Rafael L Pacheco; Ana Luiza C Martimbianco; Rachel Riera; Nicole Skoetz; Miriam Stegemann
Journal:  Cochrane Database Syst Rev       Date:  2021-10-18

Review 4.  Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.

Authors:  Christodoulos Papadopoulos; Dimitrios Patoulias; Eleftherios Teperikidis; Dimitrios Mouselimis; Anastasios Tsarouchas; Maria Toumpourleka; Aristi Boulmpou; Constantinos Bakogiannis; Michael Doumas; Vassilios P Vassilikos
Journal:  SN Compr Clin Med       Date:  2020-08-04

5.  Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model.

Authors:  Alberto Cecconi; Jean Paul Vilchez-Tschischke; Jesus Mateo; Javier Sanchez-Gonzalez; Samuel España; Rodrigo Fernandez-Jimenez; Beatriz Lopez-Melgar; Leticia Fernández Friera; Gonzalo J López-Martín; Valentin Fuster; Jesus Ruiz-Cabello; Borja Ibañez
Journal:  J Cardiovasc Transl Res       Date:  2020-03-05       Impact factor: 4.132

6.  Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases.

Authors:  Bert Malengier-Devlies; Mieke Metzemaekers; Mieke Gouwy; Erika Van Nieuwenhove; Albrecht Betrains; Maaike Cockx; Lotte Vanbrabant; Noëmie Pörtner; Jurgen Vercauteren; Lien De Somer; Sofie Struyf; Steven Vanderschueren; Ellen De Langhe; Paul Proost; Patrick Matthys; Carine Wouters
Journal:  J Clin Immunol       Date:  2021-03-05       Impact factor: 8.317

7.  Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.

Authors:  Sofia Nolasco; Javier Bellido; Marina Serna; Bruno Carmona; Helena Soares; Juan Carlos Zabala
Journal:  Front Cell Dev Biol       Date:  2021-04-22

8.  Neutrophil-mediated Thrombosis and NETosis in Behçet's Disease: a Hypothesis.

Authors:  Ezgi Deniz Batu
Journal:  J Korean Med Sci       Date:  2020-07-27       Impact factor: 2.153

Review 9.  Attenuation of acute and chronic inflammation using compounds derived from plants.

Authors:  Stephen C Bondy; Meixia Wu; Kedar N Prasad
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-06

Review 10.  The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.

Authors:  Monireh Golpour; Tahoora Mousavi; Mina Alimohammadi; Ali Mosayebian; Mohammadreza Shiran; Reza Alizadeh Navaei; Alireza Rafiei
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.